Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epigenetic modifications in osteogenic differentiation and transformation.

David Thomas1, Maya Kansara

  • 1Ian Potter Foundation Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre, Victoria 3002, Melbourne, Australia. david.thomas@petermac.org

Journal of Cellular Biochemistry
|April 7, 2006
PubMed
Summary

Tumorigenesis disrupts normal cell differentiation at two key points, involving mesenchymal stem cells and cell cycle exit. Epigenetic processes critically regulate these transitions, with genes like RUNX2 playing ambivalent roles in osteosarcoma development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Outcome Measurement in Oncology Clinical Trials Through Artificial Intelligence: A Scoping Review.

JCO clinical cancer informatics·2026
Same author

Clinical Audit of the Emergency Management of Convulsive Status Epilepticus in Children Subsequently Admitted to Paediatric Intensive Care.

Cureus·2026
Same author

Prevalence, treatment and survival of Malignant Peripheral Nerve Sheath Tumor in the Danish neurofibromatosis type 1 population.

The oncologist·2026
Same author

Cross-Institutional Validation of a novel LLM-Based Cardiac Event Extraction framework from Electronic Health Records.

International journal of radiation oncology, biology, physics·2026
Same author

Tobacco retailer density in the Northern Territory, Australia.

Rural and remote health·2026
Same author

Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma.

JTO clinical and research reports·2026

Area of Science:

  • Oncology
  • Developmental Biology
  • Epigenetics

Background:

  • Tumors exhibit aberrant cellular differentiation.
  • Osteosarcoma serves as a model for studying tumorigenesis-induced differentiation defects.
  • Normal osteoblast differentiation involves critical, tightly regulated transitions.

Purpose of the Study:

  • To elucidate how tumorigenesis perturbs normal cellular differentiation.
  • To identify key transition points in differentiation that are targets of oncogenic events.
  • To highlight the critical role of epigenetic processes in these transitions.

Main Methods:

  • Conceptual model development based on existing knowledge of osteoblast differentiation and cancer.
  • Analysis of the roles of key genes (e.g., RUNX2, Polycomb genes, retinoblastoma protein) in differentiation and tumorigenesis.

Related Experiment Videos

  • Discussion of epigenetic mechanisms in stem cell compartments and cell cycle regulation.

    • Main Results:

    • Two critical transition points in normal differentiation are identified as foci for oncogenic events.
    • Epigenetic processes are crucial at both the mesenchymal stem cell to transit-amplifying cell transition and terminal cell cycle exit.
    • Genes like RUNX2 exhibit ambivalent roles, acting oncogenically and anti-oncogenically in tumorigenesis.

    Conclusions:

    • Disruption of normal differentiation transitions by epigenetic dysregulation is central to tumorigenesis.
    • Understanding these perturbed pathways offers insights into osteosarcoma development.
    • Epigenetic regulators, including Polycomb genes and the retinoblastoma protein, are implicated in skeletal development and cancer.